Notice of Meeting, 27797-27798 [2010-11886]

Download as PDF Federal Register / Vol. 75, No. 95 / Tuesday, May 18, 2010 / Notices onto the NIH campus. All visitor vehicles, including taxis, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https://www. nichd.nih.gov/about/nachhd.htm, where an agenda and any additional information for the meeting will be posted when available. In order to facilitate public attendance at the open session of Council, reserve seating will be made available to the first five individuals reserving seats in the main meeting room, Conference Room 6. Please contact Ms. Lisa Kaeser, Program and Public Liaison Office, NICHD, at 301–496–0536 to make your reservation. Additional seating will be available in the meeting overflow rooms, Conference Rooms 7 and 8. Individuals will also be able to view the meeting via NIH Videocast. Please go to the following link for Videocast access instructions at: https://wwwauthor.nichd.nih. gov/about/overview/advisory/nachhd/virtualmeeting-201005.cfm. The meeting is partially closed to the public. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment program, National Institutes of Health, HHS) Dated: May 12, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. Password: ACCV. Agenda: The agenda items for the December meeting will include, but are not limited to: updates from the Division of Vaccine Injury Compensation (DVIC), Department of Justice, National Vaccine Program Office, Immunization Safety Office (Centers for Disease Control and Prevention), National Institute of Allergy and Infectious Diseases (National Institutes of Health), and Center for Biologics, Evaluation and Research (Food and Drug Administration). Agenda items are subject to change as priorities dictate. Public Comments: Persons interested in providing an oral presentation should submit a written request, along with a copy of their presentation to: Annie Herzog, DVIC, Healthcare Systems Bureau (HSB), Health Resources and Services Administration (HRSA), Room 11C–26, 5600 Fishers Lane, Rockville, Maryland 20857 or e-mail: aherzog@hrsa.gov. Requests should contain the name, address, telephone number, and any business or professional affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The allocation of time may be adjusted to accommodate the level of expressed interest. DVIC will notify each presenter by mail or telephone of their assigned presentation time. Persons who do not file an advance request for a presentation, but desire to make an oral statement, may announce it at the time of the comment period. These persons will be allocated time as it permits. FOR FURTHER INFORMATION CONTACT: Anyone requiring information regarding the ACCV should contact Annie Herzog, DVIC, HSB, HRSA, Room 11C–26, 5600 Fishers Lane, Rockville, MD 20857; telephone (301) 443–6593 or e-mail: aherzog@hrsa.gov. [FR Doc. 2010–11848 Filed 5–17–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: May 11, 2010. Sahira Rafiullah, Director, Division of Policy and Information Coordination. Health Resources and Services Administration [FR Doc. 2010–11837 Filed 5–17–10; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES Times and Date: 11:30 a.m.–6:30 p.m., June 17, 2010 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5, U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Section 10(d) of Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Prevention of Suicidal Behavior through the Enhancement of Connectedness (U01), RFA CE10–006’’. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Jane Suen, Dr.P.H., M.S., National Center for Injury Prevention and Control, Office of the Director, Extramural Research Program Office, 4770 Buford Highway, NE., Mailstop F– 63, Atlanta, Georgia 30341, Telephone (770) 488–4281. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: May 11, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2010–11887 Filed 5–17–10; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4165–15–P In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: mstockstill on DSKH9S0YB1PROD with NOTICES Advisory Commission on Childhood Vaccines; Notice of Meeting 27797 Name: Advisory Commission on Childhood Vaccines (ACCV). Date and Time: June 10, 2010, 1 p.m. to 5:30 p.m. EDT; June 11, 2010, 9 a.m. to 12:30 p.m. EDT. Place: Parklawn Building (and via audio conference call), Conference Rooms G & H, 5600 Fishers Lane, Rockville, MD 20857. The ACCV will meet on Thursday, June 10 from 1 pm to 5:30 pm (EDT) and Friday, June 11 from 9 a.m. to 12:30 p.m. (EDT). The public can join the meeting via audio conference call by dialing 1–888–849–8919 on June 10 & 11 and providing the following information: Leader’s Name: Dr. Geoffrey Evans. VerDate Mar<15>2010 17:22 May 17, 2010 Jkt 220001 Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Prevention of Suicidal Behavior through the Enhancement of Connectedness (U01), Request for Applications (RFA) CE10–006, initial review. In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the aforementioned meeting: PO 00000 Frm 00097 Fmt 4703 Sfmt 4703 Notice of Meeting Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Evaluation of Offering and Documenting Influenza Vaccination for Nursing Home Residents, Funding Opportunity Announcement (FOA) IP10–001; Development, Implementation, and Evaluation of a Multi-Component Intervention to Vaccinate Adolescents at Risk for Vaccine-Preventable Diseases, FOA IP10–002; Evaluation and Impact of a State Law Requiring Mandatory Influenza Vaccination of Hospital Employees, FOA IP10–003; and Improving the Translation of the E:\FR\FM\18MYN1.SGM 18MYN1 27798 Federal Register / Vol. 75, No. 95 / Tuesday, May 18, 2010 / Notices Evidence-Based Recommendation of Client Reminder/Recall for Childhood Immunization, FOA IP10–004, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the aforementioned meeting: Time and Date: 8 a.m.–5 p.m., June 7, 2010 (Closed). Place: Sheraton Gateway Hotel Atlanta Airport, 1900 Sullivan Road, Atlanta, Georgia 30337, Telephone: (770) 979–1100. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Evaluation of Offering and Documenting Influenza Vaccination for Nursing Home Residents, FOA IP10–001; Development, Implementation, and Evaluation of a Multi-Component Intervention to Vaccinate Adolescents at Risk for Vaccine-Preventable Diseases, FOA IP10– 002; Evaluation and Impact of a State Law Requiring Mandatory Influenza Vaccination of Hospital Employees, FOA IP10–003; and Improving the Translation of the EvidenceBased Recommendation of Client Reminder/ Recall for Childhood Immunization, FOA IP10–004’’. For More Information Contact: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 498–2293. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: May 11, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2010–11886 Filed 5–17–10; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HOMELAND SECURITY mstockstill on DSKH9S0YB1PROD with NOTICES Customs and Border Protection Notice of Issuance of Final Determination Concerning Certain Commodity-Based Clustered Storage Units AGENCY: U.S. Customs and Border Protection, Department of Homeland Security. ACTION: Notice of final determination. VerDate Mar<15>2010 17:22 May 17, 2010 Jkt 220001 SUMMARY: This document provides notice that U.S. Customs and Border Protection (‘‘CBP’’) has issued a final determination concerning the country of origin of certain Commodity-based Clustered Storage Units. Based upon the facts presented, CBP has concluded in the final determination that the United States is the country of origin of Commodity-based Clustered Storage Units for purposes of U.S. government procurement. Dated: May 11, 2010. William G. Rosoff, Acting Executive Director, Regulations and Rulings. The final determination was issued on May 11, 2010. A copy of the final determination is attached. Any party-at-interest, as defined in 19 CFR 177.22(d), may seek judicial review of this final determination within 30 days from date of publication in the Federal Register. Mr. Joshua Holzer Wilson, Sonsini, Goodrich & Rosati 1700 K Street, NW, Fifth Floor Washington, DC 20006–3817 RE: U.S. Government Procurement; Title III, Trade Agreements Act of 1979 (19 U.S.C. § 2511); Subpart B, Part 177, CBP Regulations; ICS Units DATES: FOR FURTHER INFORMATION CONTACT: Alison Umberger, Valuation and Special Programs Branch: (202) 325–0267. Notice is hereby given that on May 11, 2010, pursuant to subpart B of part 177, Customs Regulations (19 CFR part 177, subpart B), CBP issued a final determination concerning the country of origin of Commodity-based Clustered Storage Units which may be offered to the U.S. Government under an undesignated government procurement contract. This final determination, in HQ H082476, was issued at the request of Scale Computing under procedures set forth at 19 CFR part 177, subpart B, which implements Title III of the Trade Agreements Act of 1979, as amended (19 U.S.C. 2511–18). In the final determination, CBP has concluded that, based upon the facts presented, the Commodity-based Clustered Storage Units, assembled in the United States from parts made in China, Taiwan, India, Thailand, and Malaysia, and programmed in the United States using software developed in the United States, is substantially transformed in the United States, such that the United States is the country of origin of the finished article for purposes of U.S. government procurement. SUPPLEMENTARY INFORMATION: Section 177.29, Customs Regulations (19 CFR 177.29), provides that notice of final determinations shall be published in the Federal Register within 60 days of the date the final determination is issued. Section 177.30, CBP Regulations (19 CFR 177.30), provides that any party-at-interest, as defined in 19 CFR 177.22(d), may seek judicial review of a final determination within 30 days of publication of such determination in the Federal Register. PO 00000 Frm 00098 Fmt 4703 Sfmt 4703 Office of International Trade Attachment HQ H082476 May 11, 2010 OT:RR:CTF:VS H082476 ARU CATEGORY: Marking Dear Mr. Holzer: This is in response to your request dated October 15, 2009, made on behalf of Scale Computing (‘‘Scale’’). You ask for a country of origin marking decision and final determination relating to government procurement pursuant to subpart B of Part 177, Customs and Border Protection (‘‘CBP’’) Regulations (19 C.F.R. § 177.21 et seq.). Under these regulations, which implement Title III of the Trade Agreements Act of 1979, as amended (19 U.S.C. § 2511 et seq.), CBP issues country of origin advisory rulings and final determinations on whether an article is or would be a product of a designated country or instrumentality for the purpose of granting waivers of certain ‘‘Buy American’’ restrictions in U.S. law or practice for products offered for sale to the U.S. Government. This final determination concerns the country of origin of Scale’s SN1000, SN2000, and SN4000 Commodity-based Clustered Storage (‘‘ICS’’) Units. We note that Scale is a party-at-interest within the meaning of 19 C.F.R. § 177.22(d)(1) and is entitled to request this final determination. FACTS: Scale Computing produces storage appliances that offer a multi-protocol, multi-density suite of non-controllerbased, unified NAS/SAN, enterpriseclass storage solutions. Scale’s SN1000, SN2000, and SN4000 ICS Units are mass data storage devices similar in function to Storage Area Network (‘‘SAN’’) or Network Attached Storage (‘‘NAS’’) devices (i.e., special-purpose networks that interconnect different kinds of data storage devices—such as tape libraries and disk arrays—with associated data servers on behalf of a larger network of E:\FR\FM\18MYN1.SGM 18MYN1

Agencies

[Federal Register Volume 75, Number 95 (Tuesday, May 18, 2010)]
[Notices]
[Pages 27797-27798]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-11886]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Meeting

    Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Evaluation of Offering and Documenting Influenza 
Vaccination for Nursing Home Residents, Funding Opportunity 
Announcement (FOA) IP10-001; Development, Implementation, and 
Evaluation of a Multi-Component Intervention to Vaccinate Adolescents 
at Risk for Vaccine-Preventable Diseases, FOA IP10-002; Evaluation and 
Impact of a State Law Requiring Mandatory Influenza Vaccination of 
Hospital Employees, FOA IP10-003; and Improving the Translation of the

[[Page 27798]]

Evidence-Based Recommendation of Client Reminder/Recall for Childhood 
Immunization, FOA IP10-004, initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the aforementioned meeting:

    Time and Date: 8 a.m.-5 p.m., June 7, 2010 (Closed).
    Place: Sheraton Gateway Hotel Atlanta Airport, 1900 Sullivan 
Road, Atlanta, Georgia 30337, Telephone: (770) 979-1100.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c) (4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Evaluation of Offering and Documenting Influenza 
Vaccination for Nursing Home Residents, FOA IP10-001; Development, 
Implementation, and Evaluation of a Multi-Component Intervention to 
Vaccinate Adolescents at Risk for Vaccine-Preventable Diseases, FOA 
IP10-002; Evaluation and Impact of a State Law Requiring Mandatory 
Influenza Vaccination of Hospital Employees, FOA IP10-003; and 
Improving the Translation of the Evidence-Based Recommendation of 
Client Reminder/Recall for Childhood Immunization, FOA IP10-004''.
    For More Information Contact: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop 
E60, Atlanta, Georgia 30333, Telephone: (404) 498-2293.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: May 11, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2010-11886 Filed 5-17-10; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.